Study of stem cell therapy for amyotrophic lateral sclerosis (ALS) progression
Part of Brain & nervous system clinical trials.
This study tests whether a new treatment using special motor neuron cells made from stem cells (iPSCs) can help people with ALS. The cells will be transplanted into the spinal cord to try to slow the disease and improve function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with ALS by a neurologist and the diagnosis was made 6 to 24 months ago.
- You have already tried standard ALS treatments and they did not work well or your disease has progressed.
- Your lung function is at least 50% of what is expected for your age and height.
- You do not use a breathing machine or have a tracheostomy tube.
- You are in good overall health, with a body mass index (BMI) of 18.5 or higher.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to match people with ALS to potential treatments based on their genetic profile. It connects you to a network of trials that may be relevant to your specific type of ALS.
This study tests an experimental drug called PLL001 for people with ALS. It aims to see if the drug is safe and if it can slow the progression of the disease. You may be a good fit if you have been recently diagnosed and are still in the early stages of ALS.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
This trial tests a new treatment made from stem cells (called XS228CN) injected into the spine. It is primarily a safety study, but doctors will also watch for any signs the treatment may slow ALS progression.
This trial tests whether injecting neural stem cells into the spine can slow down ALS. It is for people with rapidly progressing ALS who have good lung function and a caregiver to help with visits.
Hear when a new ALS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.